4PRG

0072 PARTIAL AGONIST PPAR GAMMA COCRYSTAL


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.9 Å
  • R-Value Free: 0.283 
  • R-Value Work: 0.240 

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history

Literature

A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation.

Oberfield, J.L.Collins, J.L.Holmes, C.P.Goreham, D.M.Cooper, J.P.Cobb, J.E.Lenhard, J.M.Hull-Ryde, E.A.Mohr, C.P.Blanchard, S.G.Parks, D.J.Moore, L.B.Lehmann, J.M.Plunket, K.Miller, A.B.Milburn, M.V.Kliewer, S.A.Willson, T.M.

(1999) Proc.Natl.Acad.Sci.USA 96: 6102-6106

  • Also Cited By: 2I4Z, 2I4P, 2I4J

  • PubMed Abstract: 
  • The peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that regulate glucose and lipid homeostasis. The PPARgamma subtype plays a central role in the regulation of adipogenesis and is the molecular target for the 2, 4-t ...

    The peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that regulate glucose and lipid homeostasis. The PPARgamma subtype plays a central role in the regulation of adipogenesis and is the molecular target for the 2, 4-thiazolidinedione class of antidiabetic drugs. Structural studies have revealed that agonist ligands activate the PPARs through direct interactions with the C-terminal region of the ligand-binding domain, which includes the activation function 2 helix. GW0072 was identified as a high-affinity PPARgamma ligand that was a weak partial agonist of PPARgamma transactivation. X-ray crystallography revealed that GW0072 occupied the ligand-binding pocket by using different epitopes than the known PPAR agonists and did not interact with the activation function 2 helix. In cell culture, GW0072 was a potent antagonist of adipocyte differentiation. These results establish an approach to the design of PPAR ligands with modified biological activities.


    Related Citations: 
    • Ligand Binding and Co-Activator Assembly of the Peroxisome Proliferator Activated Receptor
      Nolte, R.T.,Wisely, G.B.,Westin, S.,Cobb, J.E.,Lambert, M.H.,Kurokawa, R.,Rosenfeld, M.G.,Willson, T.M.,Glass, C.K.,Milburn, M.V.
      (1998) Nature 395: 137


    Organizational Affiliation

    Department of Molecular Endocrinology, Glaxo Wellcome Research and Development, Research Triangle Park, NC 27709, USA.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
PROTEIN (PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA)
A, B, C, D
270Homo sapiensMutation(s): 0 
Gene Names: PPARG (NR1C3)
Find proteins for P37231 (Homo sapiens)
Go to Gene View: PPARG
Go to UniProtKB:  P37231
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
072
Query on 072

Download SDF File 
Download CCD File 
A, B, C, D
(+/-)(2S,5S)-3-(4-(4-CARBOXYPHENYL)BUTYL)-2-HEPTYL-4-OXO-5-THIAZOLIDINE
THIAZOLIDINONE; GW0072
C37 H46 N2 O4 S
GHJJBEKMPCOSRH-LRHLLKFHSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
72Ki: 70 nM PDBBIND
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.9 Å
  • R-Value Free: 0.283 
  • R-Value Work: 0.240 
  • Space Group: P 1 2 1
Unit Cell:
Length (Å)Angle (°)
a = 92.720α = 90.00
b = 61.540β = 102.57
c = 118.810γ = 90.00
Software Package:
Software NamePurpose
SCALEPACKdata scaling
DENZOdata reduction
CNSrefinement

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

  • Deposited Date: 1999-05-07 
  • Released Date: 1999-05-27 
  • Deposition Author(s): Milburn, M.V.

Revision History 

  • Version 1.0: 1999-05-27
    Type: Initial release
  • Version 1.1: 2008-04-26
    Type: Version format compliance
  • Version 1.2: 2011-07-13
    Type: Version format compliance